The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Seborrheic Dermatitis: Management

Common chronic relapsing inflammatory skin disorder of seborrheic areas (scalp, face, chest, intertriginous folds) associated with Malassezia yeast colonization and individual susceptibility, requiring long-term maintenance therapy.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Dermatoloji department. Book Appointment →

What is Seborrheic Dermatitis: Management?

Seborrheic dermatitis (SD) is a common chronic relapsing inflammatory skin condition affecting sebum-rich areas including scalp (most common), eyebrows, glabella, nasolabial folds, ears, beard area, anterior chest, axillae, and groin/intertriginous folds. Prevalence is 1-3% in healthy adults and significantly higher (up to 30-83%) in HIV/AIDS, Parkinson disease, and immunocompromised states.

Pathogenesis involves overgrowth of commensal Malassezia yeast (especially M. globosa, M. restricta) on sebum-rich skin, lipase-mediated breakdown of sebum into inflammatory free fatty acids, and host immune response. Genetic predisposition and impaired skin barrier function contribute. Infantile SD (cradle cap) is self-limited; adult-onset SD typically has chronic relapsing course.

Clinical features include erythematous patches with greasy yellowish scales on involved areas, mild to moderate pruritus, scalp dandruff (mild form), and exacerbation with stress, cold weather, and seasonal changes. Differential diagnosis includes psoriasis (sharper borders, silvery scale), atopic dermatitis, rosacea, and tinea capitis. Management is long-term: topical antifungals (ketoconazole 2%, ciclopirox), low-potency corticosteroids for acute flares (hydrocortisone 1-2.5%), calcineurin inhibitors (tacrolimus, pimecrolimus) for face avoiding steroid atrophy, medicated shampoos (zinc pyrithione, selenium sulfide, coal tar, salicylic acid), and avoidance of irritants.

Symptoms

Erythematous patches with greasy yellowish scales
Scalp involvement: dandruff (mild) to thick scales with erythema
Eyebrows, glabella, nasolabial folds, ears, beard area
Anterior chest (presternal area), back, axillae, groin
Mild to moderate pruritus and burning
Exacerbation with stress, cold weather, seasonal changes

Risk Factors

HIV/AIDS (severe and refractory)
Parkinson disease and other neurologic conditions
Stress, depression, mood disorders
Cold dry climate, seasonal (winter worse)
Male sex (slight predominance), age 30-60 or infantile
Immunocompromised states, organ transplantation

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Persistent dandruff not responding to OTC shampoos
  • Erythema and scales on face (especially nasolabial folds, eyebrows)
  • Severe scalp itching with scales
  • Suspected secondary bacterial infection (oozing, crusting)
  • Widespread or atypical distribution
  • Suspected underlying condition (HIV, Parkinson)

Treatment Methods

01
Clinical diagnosis based on characteristic distribution; KOH if tinea suspected; biopsy rarely needed
02
Scalp: ketoconazole 2% shampoo, ciclopirox 1% shampoo, zinc pyrithione, selenium sulfide, coal tar, salicylic acid (use 2-3x/week, leave on 5-10 minutes)
03
Topical corticosteroids (low-potency for face: hydrocortisone 1-2.5%; mid-potency for body) for acute flares
04
Topical calcineurin inhibitors (tacrolimus 0.1%, pimecrolimus 1%) for facial maintenance avoiding steroid atrophy
05
Topical antifungals: ketoconazole 2% cream, ciclopirox 0.77%, terbinafine
06
Severe/refractory: oral antifungals (itraconazole, fluconazole), oral isotretinoin (low dose)
07
Avoid harsh soaps and frequent shampoos; manage stress; treat underlying conditions
08
Long-term maintenance with antifungal shampoo 1-2x/week to prevent recurrence
09
HIV-associated SD: HAART improves; baby SD (cradle cap): emollients, soft brushing, baby shampoo

Which Department to Visit?

You can visit our Dermatoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Dermatoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Eczema (Atopic Dermatitis)

Dermatoloji

Atopic dermatitis is a chronic skin disease commonly seen especially in children, flaring with genetic predisposition and environmental triggers.

Psoriasis

Dermatoloji

Psoriasis is an autoimmune disease in which skin cells proliferate rapidly when the immune system mistakenly attacks the skin, leading to thick scaly lesions.

Acne

Dermatoloji

Acne is a skin disease resulting from clogging of hair follicles with oil and dead skin cells, commonly seen in adolescence but can occur at any age.

Rosacea

Dermatoloji

Rosacea is a chronic inflammatory facial skin disease characterized by recurrent flushing, persistent erythema, telangiectasia, and inflammatory papules and pustules. Phymatous change and ocular involvement may complicate advanced disease.

Urticaria (Hives)

Dermatoloji

Urticaria is a skin condition with sudden pink-red wheals and intense itching that may follow an acute or chronic course.

Skin Fungal Infections

Dermatoloji

Skin fungal infections are common, contagious skin diseases caused by dermatophytes and yeast fungi colonizing the upper layers of the skin.

Hair Loss (Alopecia)

Dermatoloji

Alopecia is a general term for hair loss that can be genetic, hormonal, autoimmune, or nutritional; early intervention can slow progression.

Vitiligo

Dermatoloji

Vitiligo is an acquired autoimmune disease in which CD8+ T cells destroy melanocytes, producing well-demarcated depigmented patches. Early, sustained treatment can induce repigmentation and prevent progression; psychosocial impact warrants holistic care.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.